2024 Pharmacy Pearls for Prescribers - CKD

Instructions to Receive Credit

Monday, July 1, 2024, 8:00 AM - Wednesday, July 1, 2026, 5:00 PM

Pharmacy Pearls for Prescribers provides up-to-date information on medications, developed by a multidisciplinary group of AMG primary care physicians and pharmacists from Avera Health and Avera Health Insurance Division. An interdisciplinary group has been working to develop educational materials to meet this need. In this series we will discuss CKD management related to: screening and monitoring of CKD, SGLT-2 Inhibitors in CKD, and ACEis and ARBs in Proteinuric CKD.

1. Discuss screening and monitoring of CKD
2. Identify stages and prognosis of CKD
3. Evaluate methods to lower blood pressure in order to reduce the mortality of patients with CKD
4. Describe how SGLT-2 inhibitors may have beneficial effects on CKD progression
5. Describe how a multidisciplinary collaboration can contribute to continuous and reliable patient care

Bibliography

ADA Statement:
If you require ADA accommodations, please indicate what your needs are at the time of registration. We cannot ensure the availability of appropriate accommodations without prior notification.

Disclaimer:
All educational materials provided during and after the course are for your personal use only and should not be reproduced or distributed in any manner.

In support of improving patient care, Avera is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Credit Designations:

	This activity was planned by and for the healthcare team, and learners will receive 1.0 IPCE credits for learning and change.
	Medicine CME:  Avera designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program.  It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
	Nurse CE: Avera designates this activity for a maximum of 1.0 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity. Nursing Pharmacotherapeutic This activity has been approved for 1.00 pharmacotherapeutic credit(s).
	Pharmacy CE: Avera designates this activity for 1.00 ACPE contact hour(s). Pharmacists and pharmacy technicians should claim only the credit commensurate with the extent of their participation in the activity. Credit will be uploaded to the NABP CPE Monitor® within 30 days after the activity completion. Per ACPE rules, Avera does not have access nor the ability to upload credits requested after the evaluation closes. It is the responsibility of the pharmacist or pharmacy technician to provide the correct information (NABP ID and DOB (MMDD)) to receive credit.

Mitigation of Relevant Financial Relationships

Avera adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.

Individuals in a position to control the content of this CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible companies. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed below have been mitigated prior to the commencement of the activity.